EP3969620
GENOME-BASED METHODS FOR REDUCING CARDIOVASCULAR RISK
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
16.5.2020:
25.6.2025:
20730885.9
:
15.5.2040:
15.5.2026
:
GENOME-BASED METHODS FOR REDUCING CARDIOVASCULAR RISK
16.5.2020
25.6.2025
15.5.2026
:
Regeneron Pharmaceuticals, Inc.:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
:
DAMASK, Amy:
Tarrytown, New York 10591-6707, US
:
PAULDING, Charles:
Tarrytown, New York 10591-6707, US
:
BARAS, Aris:
Tarrytown, New York 10591-6707, US
:
ABECASIS, Goncalo:
Tarrytown, New York 10591-6707, US
:
201962849670 P:
17.5.2019:
US
:
201962933181 P:
8.11.2019:
US
:
US2020033315:
16.5.2020
:
C12Q 1/6883